Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Corbus Pharmaceuticals Holdings, Inc. (CRBP)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Operating expenses:          
Research and development  16.136.498.389.648.626.015.45.9
General and administrative  18.720.428.523.613.09.06.53.6
Litigation settlement  5.0       
    Total operating expenses  39.856.9126.7113.261.635.021.99.5
    Operating loss  -39.8-56.0-122.8-77.1-56.7-32.6-20.0-8.9
   
Other income (expense), net:          
Other income (expense), net  0.011.913.3     
Interest income (expense), net  -2.1-1.8-1.01.21.00.20.00.0
Foreign currency exchange gain (loss), net  -0.4-0.4-0.4-0.20.10.00.00.0
    Other expense, net  -2.521.924.45.71.10.10.00.0
    Net loss  -42.3-45.6-111.3     
   
Earnings Per Share, Basic  ($10.15)($11.15)($1.42)($1.12)($0.98)($0.65)($0.49)($0.28)
Earnings Per Share, Diluted  ($10.15)($11.15)($1.42)($1.12)($0.98)($0.65)($0.49)($0.28)
   
Weighted Average Number of Shares Outstanding, Basic  4.24.178.163.957.050.241.131.4
Weighted Average Number of Shares Outstanding, Diluted  4.24.178.163.957.0   
   
Comprehensive loss:          
Net loss  -42.3-45.6-111.3-71.5-55.7-32.4-20.0-8.9
   
Other comprehensive income (loss):          
Change in unrealized gain (loss) on marketable debt securities  -0.1-0.1      
   
    Total other comprehensive income (loss)          
    Total comprehensive loss  -42.4-45.7-111.3     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy